Home Trending Stocks Why India Globalization Capital, Inc. (IGC) stock is Going high today?

Why India Globalization Capital, Inc. (IGC) stock is Going high today?

Shares of India Globalization Capital, Inc. (IGC) stock continued to rise today on June 8, 2021, after rising as much as 21.58% at the previous closing. IGC stock price saw an uptrend of 7.69% to reach $1.82 a share as of this writing. IGC stock recently announced the completion of Cohort 2 of its  Phase 1tetrahydrocannabinol-based clinical trial of IGC-AD1on patients with Alzheimer’s disease. Let’s deep dive to explore more of it.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Cohort 1 and 2 of Phase 1 Clinical Trial

Previously On May 14, IGC stock did announce the completion of Cohort 1 of phase 1 clinical trial of the same drug pursuant to which each participant of the trial was given one dose per day. In Cohort 2, two doses per day were given to each participant of the trial. After reviewing the data from Cohort 1 and Cohort 2, the data and safety monitoring committee has recommended Cohort three in which three doses per day would be given to the participants. Every participant is daily monitored for safety as well as certain behavioral changes. The phase 1 clinical trial is expected to be complete during the period between July and September 2021. Last year,  IGC stock submitted the IGC-AD1 to the FDA and got the approval for conducting the trial on July 30, 2020.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Impact of Alzheimer Disease and role of IGC-AD1

According to the estimates by the world health organization (WHO), roughly 50 million individuals would be impacted by Alzheimer’s diseases by the end of 2030. IGC-AD1 is mainly intended to reduce the symptoms which individuals suffering from Alzheimer’s disease usually show. The severe condition causes loss of memory and dementia in Alzheimer’s patients. The current trial of IGC-AD1 is focused on the safety of the drug and if IGC stock gets better results from the first trial and appropriate FDA approvals, then it would further proceed the clinical study in order to evaluate the efficacy of the drug in the future.

Conclusion

So far so good for IGC stock as far as market sentiment is concerned. Even in the COVID-19 era, the India Globalization stock remained focused on Alzheimer’s disease and continuously put efforts to reach this stage. Now IGC stock is looking forward to proceeding with Cohort 3  to further evaluate the safety of the drug. In a nutshell, investors need to keep an eye on this penny stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Corbus Pharmaceuticals Holdings Inc. (CRBP) stock plunged during current market. Let’s find out why?

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock fell by 11.31% during the current trading session. By expanding on their core knowledge in immunology, Corbus...

ServiceSource International Inc. (SREV) stock plunged during pre-market, prior to no recent news.

ServiceSource International Inc. (NASDAQ: SREV) stock gained by 3.51% at the last close whereas the SREV stock-price fell by 0.85% in the pre-market trading...

Why Accuray Incorporated (ARAY) stock had a good Wednesday?

Accuray Incorporated (ARAY) shares rose 4.86% in after-hours on Wednesday, June 23, 2021, and closed at $4.75 per share. Earlier in the morning session,...

Reto Eco-Solutions Inc. (RETO) stock declines during after-hour session. Let’s see why?

Reto Eco-Solutions Inc. (NASDAQ: RETO) stock gained by 12.82% at last close whereas the RETO stock-price fell by 5.3% in the after-hour session. ReTo...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Broadstone Net Lease Inc. (BNL) stock plunged during pre-market trading. Let’s see why?

Broadstone Net Lease Inc. (NASDAQ: BNL) stock gained by 1.39% at the last close whereas the BNL stock price fell by 5.41% in the...

ServiceSource International Inc. (SREV) stock plunged during pre-market, prior to no recent news.

ServiceSource International Inc. (NASDAQ: SREV) stock gained by 3.51% at the last close whereas the SREV stock-price fell by 0.85% in the pre-market trading...

Orphazyme Inc. (ORPH) stock soars during pre-market trading. Here’s what you should know?

Orphazyme Inc. (NASDAQ: ORPH) stock gained by 24.62% at last close while the ORPH stock price surged by 9.27% in the pre-market trading session....

Related News

Corbus Pharmaceuticals Holdings Inc. (CRBP) stock plunged during current market. Let’s find out why?

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock fell by 11.31% during the current trading session. By expanding on their core knowledge in immunology, Corbus...

ServiceSource International Inc. (SREV) stock plunged during pre-market, prior to no recent news.

ServiceSource International Inc. (NASDAQ: SREV) stock gained by 3.51% at the last close whereas the SREV stock-price fell by 0.85% in the pre-market trading...

Why Accuray Incorporated (ARAY) stock had a good Wednesday?

Accuray Incorporated (ARAY) shares rose 4.86% in after-hours on Wednesday, June 23, 2021, and closed at $4.75 per share. Earlier in the morning session,...

Reto Eco-Solutions Inc. (RETO) stock declines during after-hour session. Let’s see why?

Reto Eco-Solutions Inc. (NASDAQ: RETO) stock gained by 12.82% at last close whereas the RETO stock-price fell by 5.3% in the after-hour session. ReTo...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam